P Marteau

Summary

Country: France

Publications

  1. ncbi request reprint Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine
    B Bonaz
    Département d Hépato Gastroentérologie, CHU de Grenoble, France
    Aliment Pharmacol Ther 18:401-8. 2003
  2. ncbi request reprint Probiotics and intestinal health effects: a clinical perspective
    P Marteau
    Gastroenterology Department, Hopital Europeen Georges Pompidou, Assistance Publique des Hopitaux de Paris, 20 rue Leblanc, 75908 CEDEX 15, France
    Br J Nutr 88:S51-7. 2002
  3. doi request reprint A randomized, double-blind, controlled study and pooled analysis of two identical trials of fermented milk containing probiotic Bifidobacterium lactis CNCM I-2494 in healthy women reporting minor digestive symptoms
    P Marteau
    Department of Digestive Diseases, AP HP, Lariboisiere Hospital, University Denis Diderot, Paris, France
    Neurogastroenterol Motil 25:331-e252. 2013
  4. pmc Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial
    P Marteau
    Department Gastroenterology, Hopital Europeen Georges Pompidou, Paris, France
    Gut 55:842-7. 2006
  5. doi request reprint Bacteria as trigger for chronic gastrointestinal disorders
    Philippe Marteau
    AP HP, Lariboisiere Hospital, Department of Digestive Diseases, Paris 7 University, Paris, France
    Dig Dis 29:166-71. 2011
  6. doi request reprint [The clinical importance of intestinal microbiota]
    P Marteau
    Medical Surgical Digestive Pathology Department, Hopital Lariboisiere, AP HP, 2 rue Ambroise Pare, Paris, France
    Gastroenterol Clin Biol 34:S93-7. 2010
  7. doi request reprint Bacterial flora in inflammatory bowel disease
    Philippe Marteau
    University Paris 7 and AP HP, Medicosurgical Department of Digestive Diseases, Lariboisiere Hospital, Paris, France
    Dig Dis 27:99-103. 2009
  8. doi request reprint Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
    P Marteau
    AP HP, Hopital Lariboisiere, Medicosurgical Department of Digestive Diseases, Laboratoire de Biologie EA 3199, CNAM and University Diderot Paris 7, Paris, France
    Gastroenterol Clin Biol 33:S228-34. 2009
  9. doi request reprint Accuracy of imaging for predicting operative approach in Crohn's disease
    B Malgras
    Department of Digestive Diseases, Hôpital Lariboisière Assistance Publique Hôpitaux de Paris, France
    Br J Surg 99:1011-20. 2012
  10. ncbi request reprint Inflammatory bowel disease: what is new?
    P Marteau
    Department of Gastroenterology, Georges Pompidou European Hospital, Paris, and University of Paris V, France
    Endoscopy 36:130-6. 2004

Detail Information

Publications45

  1. ncbi request reprint Tioguanine in patients with Crohn's disease intolerant or resistant to azathioprine/mercaptopurine
    B Bonaz
    Département d Hépato Gastroentérologie, CHU de Grenoble, France
    Aliment Pharmacol Ther 18:401-8. 2003
    ..Tioguanine (TG) is an antimetabolite which may be regarded as an alternative to azathioprine (AZA)/mercaptopurine (MP) in patients with inflammatory bowel diseases...
  2. ncbi request reprint Probiotics and intestinal health effects: a clinical perspective
    P Marteau
    Gastroenterology Department, Hopital Europeen Georges Pompidou, Assistance Publique des Hopitaux de Paris, 20 rue Leblanc, 75908 CEDEX 15, France
    Br J Nutr 88:S51-7. 2002
    ..We also analysed the recent randomised controlled trials performed in patients with Clostridium difficile or Helicobacter pylori, inflammatory bowel disease, irritable bowel syndrome, non-ulcer dyspepsia and colon cancer...
  3. doi request reprint A randomized, double-blind, controlled study and pooled analysis of two identical trials of fermented milk containing probiotic Bifidobacterium lactis CNCM I-2494 in healthy women reporting minor digestive symptoms
    P Marteau
    Department of Digestive Diseases, AP HP, Lariboisiere Hospital, University Denis Diderot, Paris, France
    Neurogastroenterol Motil 25:331-e252. 2013
    ..Our objective is to confirm these findings in a second study and in a pooled analysis of both studies...
  4. pmc Ineffectiveness of Lactobacillus johnsonii LA1 for prophylaxis of postoperative recurrence in Crohn's disease: a randomised, double blind, placebo controlled GETAID trial
    P Marteau
    Department Gastroenterology, Hopital Europeen Georges Pompidou, Paris, France
    Gut 55:842-7. 2006
    ..Bacteria are involved, and probiotics may modulate immune responses to the intestinal flora. Here we tested the probiotic strain Lactobacillus johnsonii LA1 in this setting...
  5. doi request reprint Bacteria as trigger for chronic gastrointestinal disorders
    Philippe Marteau
    AP HP, Lariboisiere Hospital, Department of Digestive Diseases, Paris 7 University, Paris, France
    Dig Dis 29:166-71. 2011
    ..Finally, important perspectives are opened by new tools such as metagenomics and metabolomics of the gastrointestinal ecosystems. Major tracks concern irritable bowel syndrome, colon cancer and obesity...
  6. doi request reprint [The clinical importance of intestinal microbiota]
    P Marteau
    Medical Surgical Digestive Pathology Department, Hopital Lariboisiere, AP HP, 2 rue Ambroise Pare, Paris, France
    Gastroenterol Clin Biol 34:S93-7. 2010
    ..This article summarizes the historical steps of these discoveries and reviews what the "modern" clinician should know in this very dynamic area in regard to research and practical consequences...
  7. doi request reprint Bacterial flora in inflammatory bowel disease
    Philippe Marteau
    University Paris 7 and AP HP, Medicosurgical Department of Digestive Diseases, Lariboisiere Hospital, Paris, France
    Dig Dis 27:99-103. 2009
    ..Taken together, these results suggest that dysbiosis, or an imbalance within the (dominant) intestinal microbiota, may favour IBD...
  8. doi request reprint Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors?
    P Marteau
    AP HP, Hopital Lariboisiere, Medicosurgical Department of Digestive Diseases, Laboratoire de Biologie EA 3199, CNAM and University Diderot Paris 7, Paris, France
    Gastroenterol Clin Biol 33:S228-34. 2009
    ..We also discuss the mechanisms of action, the use of microbial agents as pharmacological vectors, the development of genetically modified probiotics (including a clinical pilot trial in patients with Crohn's disease), and safety issues...
  9. doi request reprint Accuracy of imaging for predicting operative approach in Crohn's disease
    B Malgras
    Department of Digestive Diseases, Hôpital Lariboisière Assistance Publique Hôpitaux de Paris, France
    Br J Surg 99:1011-20. 2012
    ..The aim of this study was to assess the accuracy of preoperative imaging in detecting the extent of disease and predicting the operative approach in patients with Crohn's disease...
  10. ncbi request reprint Inflammatory bowel disease: what is new?
    P Marteau
    Department of Gastroenterology, Georges Pompidou European Hospital, Paris, and University of Paris V, France
    Endoscopy 36:130-6. 2004
    ....
  11. ncbi request reprint Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease
    P Seksik
    Département d Hépato Gastroentérologie, Hopital Saint Antoine, AP HP, Paris, France
    Aliment Pharmacol Ther 24:11-8. 2006
    ..Studies searching for a generalized or localized dysbiosis in IBD are discussed, as well as those trying to identify bacterial molecules and receptors, which may be implicated in triggering the inflammatory process...
  12. doi request reprint Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort
    A Vienne
    Department of Gastroenterology, AP HP, Saint Antoine Hospital and UPMC Univ Paris 06, Paris, France
    Aliment Pharmacol Ther 34:188-95. 2011
    ..Surveillance colonoscopy is recommended for inflammatory bowel disease (IBD) patients with longstanding extensive colitis (LEC)...
  13. ncbi request reprint [Management of ileal stenosis in patients with Crohn's disease]
    J Coelho
    Département médicochirurgical de pathologie digestive, Hopital Lariboisiere, 2 rue Ambroise Pare, Paris, France
    Gastroenterol Clin Biol 33:F75-81. 2009
    ..The treatment decision takes into account the results of radiological assessment, CRP level and the effects of the previous treatments...
  14. doi request reprint Plexitis as a predictive factor of early postoperative clinical recurrence in Crohn's disease
    H Sokol
    AP HP, Saint Antoine Hospital, Gastroenterology and Nutrition Department, Paris, France
    Gut 58:1218-25. 2009
    ..The aim of the present study was to assess the predictive value of plexitis for early clinical CD recurrence...
  15. ncbi request reprint Push enteroscopy in celiac sprue and refractory sprue
    C Cellier
    Department of Hepato Gastroenterology, Laennec Hospital and Necker Hospital, Assistance Publique Hôpitaux de Paris and Université René Descartes, Paris, France
    Gastrointest Endosc 50:613-7. 1999
    ..The aim of this study was to determine in patients with sprue whether jejunal endoscopy improves the diagnostic yield or provides information that may modify management, when compared with evaluation limited to the duodenum...
  16. doi request reprint The efficacy and safety of a third anti-TNF monoclonal antibody in Crohn's disease after failure of two other anti-TNF antibodies
    M Allez
    Hopital Saint Louis, APHP, Universite Paris 7, Paris, France
    Aliment Pharmacol Ther 31:92-101. 2010
    ..Adalimumab (ADA) and certolizumab pegol (CZP) have demonstrated efficacy in Crohn's disease (CD) patients previously treated with infliximab (IFX)...
  17. doi request reprint Clinical evidence for immunomodulatory effects of probiotic bacteria
    F M Ruemmele
    Department of Pediatrics, Hopital Necker Enfants Malades, Paris, France
    J Pediatr Gastroenterol Nutr 48:126-41. 2009
    ....
  18. ncbi request reprint Collagenous gastritis
    X Dray
    Département de Pathologie Digestive, Hopital Lariboisiere, AP HP, Paris 7 University, Paris, France
    Endoscopy 39:E292-3. 2007
  19. ncbi request reprint Infliximab for refractory ulcerative colitis or indeterminate colitis: an open-label multicentre study
    J M Gornet
    Department of Gastroenterology, Hopital Saint Louis, Paris, France
    Aliment Pharmacol Ther 18:175-81. 2003
    ..The efficacy of infliximab in ulcerative colitis (UC) and indeterminate colitis has been poorly assessed and preliminary results are conflicting...
  20. ncbi request reprint Nutritional advantages of probiotics and prebiotics
    P Marteau
    ISTNA INSERM U557 INRA U1125 EA CNAM 3200, Paris, France
    Br J Nutr 87:S153-7. 2002
    ..Positive trials have suggested preventive effects against intestinal colonization with specific gut pathogens including Clostridium difficile and Helicobacter pylori...
  21. ncbi request reprint Foetal outcome in women with inflammatory bowel disease treated during pregnancy with oral mesalazine microgranules
    P Marteau
    Service d Hepato Gastroenterologie, Hopital Laennec, Paris, France
    Aliment Pharmacol Ther 12:1101-8. 1998
    ..Little information is available about the safety of high doses of mesalazine during pregnancy...
  22. doi request reprint Flexible versus rigid single-port peritoneoscopy: a randomized controlled trial in a live porcine model followed by initial experience in human cadavers
    Y Ladjici
    Department of Digestive Diseases, Tertiary Care Centre for Peritoneal Carcinomatosis, School of Surgery, Paris, France
    Surg Endosc 26:2651-7. 2012
    ..We compared single incision laparoscopic surgery with flexible endoscope ("flexible SILS") and with rigid optic ("rigid SILS") for access to 11 elective sites of peritoneal carcinomatosis...
  23. doi request reprint Pregnancy outcome in patients with inflammatory bowel disease treated with thiopurines: cohort from the CESAME Study
    Jessica Coelho
    Department of Digestive Diseases, Lariboisiere Hospital, Paris, France
    Gut 60:198-203. 2011
    ..The aim of this study was to evaluate the pregnancy outcome of women with IBD who have been exposed to thiopurines...
  24. ncbi request reprint Review article: gut flora and inflammatory bowel disease
    P Marteau
    Département d Hépato Gastroentérologie, Hopital Europeen Georges Pompidou, Paris, France
    Aliment Pharmacol Ther 20:18-23. 2004
    ..The possibility of modifying the ecosystem using prebiotics or probiotics offers hope for new treatment developments, particularly in the prevention of relapse...
  25. pmc Comparative study of bacterial groups within the human cecal and fecal microbiota
    P Marteau
    INSERM U 290, Paris, France
    Appl Environ Microbiol 67:4939-42. 2001
    ..Facultative anaerobes represented 25% of total bacteria in the cecum versus 1% in the feces...
  26. ncbi request reprint [Digestive and nutritional management of adults with cystic fibrosis]
    P Marteau
    Service de Gastroenterologie, Hopital Europeen Georges Pompidou, Paris
    Rev Mal Respir 17:785-97. 2000
    ....
  27. pmc Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study
    P Marteau
    Gastroenterology, Hopital Europeen Georges Pompidou, 20 rue Leblanc, 75908 Paris Cedex 15, France
    Gut 54:960-5. 2005
    ....
  28. doi request reprint Validation of a live animal model for training in endoscopic hemostasis of upper gastrointestinal bleeding ulcers
    M Camus
    Gastroenterology and School of Surgery, Lariboisiere Hospital, APHP, Paris 7 University, Paris, France
    Endoscopy 45:451-7. 2013
    ..The management of upper gastrointestinal bleeding requires training of the endoscopist. We aimed to validate a live animal model of bleeding ulcers for training in endoscopic hemostasis...
  29. ncbi request reprint Tolerance to low-digestible carbohydrates: symptomatology and methods
    P Marteau
    Gastroenterology Department, European Hospital Georges Pompidou, Paris, France
    Br J Nutr 85:S17-21. 2001
    ..Double-blind, placebo-controlled studies are required to assess the subjective symptoms of intolerance, and the experimental conditions may influence the results...
  30. ncbi request reprint Bifidobacterium animalis strain DN-173 010 shortens the colonic transit time in healthy women: a double-blind, randomized, controlled study
    P Marteau
    Gastroenterology Department, European Hospital Georges Pompidou, Paris, France
    Aliment Pharmacol Ther 16:587-93. 2002
    ..A previous study has suggested that Bifidobacterium animalis DN-173 010 shortens the colonic transit time in women...
  31. doi request reprint [The future of gastrointestinal therapeutic endoscopy: NOTES]
    X Dray
    Conservatoire National des Arts et Metiers, Assistance Publique Hopitaux de Paris, Université Diderot Paris 7, Paris, France
    Gastroenterol Clin Biol 33:758-66. 2009
    ..Overall, NOTES is believed to make evolve both interventional endoscopy and minimally invasive surgery...
  32. ncbi request reprint Mycobacterium avium duodenal infection mimicking Whipple's disease in a patient with AIDS
    X Dray
    Département de Pathologie Digestive, APHP, Hopital Lariboisiere, Universite Paris 7, Paris, France
    Endoscopy 39:E296-7. 2007
  33. ncbi request reprint Malnutrition in adults with cystic fibrosis
    X Dray
    Service d Hepato gastro enterologie, Hopital Europeen Georges Pompidou, Paris, France
    Eur J Clin Nutr 59:152-4. 2005
    ..To determine the prevalence and clinical features of malnutrition and its relationship with the CFTR genotype in a cystic fibrosis (CF) adult population...
  34. ncbi request reprint Long-term outcome of patients with gastrointestinal bleeding of obscure origin explored by push enteroscopy
    B Landi
    Department of Hepatogastroenterology, Georges Pompidou European Hospital, Paris, France
    Endoscopy 34:355-9. 2002
    ..The aim of this study was to assess the rate of recurrent bleeding and its predictive factors in patients with gastrointestinal bleeding of obscure origin, after exploration by push enteroscopy...
  35. ncbi request reprint Inflammatory bowel disease
    P Marteau
    Department of Gastroenterology, Hopital Europeen Georges Pompidou, Assistance Publique des Hopitaux de Paris, and Paris V University, France
    Endoscopy 34:63-8. 2002
    ....
  36. doi request reprint A double blind randomized controlled trial of a probiotic combination in 100 patients with irritable bowel syndrome
    S Drouault-Holowacz
    PiLeJe, 37, quai de Grenelle, bâtiment Pollux, 75738 Paris Cedex 15, France
    Gastroenterol Clin Biol 32:147-52. 2008
    ..The purpose of this study was to evaluate the effects of a probiotic combination on symptoms in patients with irritable bowel syndrome (IBS)...
  37. ncbi request reprint [MR imaging of ano-perineal suppurations]
    C A Cuenod
    Service de Radiologie, Hopital Europeen Georges Pompidou, 20 rue Leblanc, 75015 Paris
    J Radiol 84:516-28. 2003
    ....
  38. pmc Alterations of the dominant faecal bacterial groups in patients with Crohn's disease of the colon
    P Seksik
    INRA, CR de Jouy en Josas, 78352 Jouy en Josas, France
    Gut 52:237-42. 2003
    ..We investigated potential differences in the faecal microflora between patients with colonic CD in remission (n=9), patients with active colonic CD (n=8), and healthy volunteers (n=16) using culture independent techniques...
  39. ncbi request reprint Safety of probiotics that contain lactobacilli or bifidobacteria
    S P Borriello
    Central Public Health Laboratory, London, United Kingdom
    Clin Infect Dis 36:775-80. 2003
    ..Vigilance regarding the detection of possible rare cases of infection due to probiotics should be maintained, and isolates should be sent to reference centers for molecular characterization and confirmation...
  40. doi request reprint Dysbiosis in inflammatory bowel disease: a role for bacteriophages?
    P Lepage
    Gut 57:424-5. 2008
  41. pmc Probiotics, prebiotics, synbiotics: ecological treatment for inflammatory bowel disease?
    P Marteau
    Gut 55:1692-3. 2006
  42. ncbi request reprint [Endoscopic treatment of lower intestinal haemorrhage of diverticular origin]
    E Cuillerier
    Gastroenterol Clin Biol 27:558-9. 2003
  43. pmc European evidence based consensus on the diagnosis and management of Crohn's disease: current management
    S P L Travis
    John Radcliffe Hospital, Oxford OX3 9DU, UK
    Gut 55:i16-35. 2006
    ..The third section on special situations in Crohn's disease includes postoperative recurrence, fistulating disease, paediatrics, pregnancy, psychosomatics, extraintestinal manifestations, and alternative therapy for Crohn's disease...
  44. pmc Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach
    C Manichanh
    Unité d Ecologie et de Physiologie du Système Digestif, INRA UEPSD, 78350 Jouy en Josas, France
    Gut 55:205-11. 2006
    ..However, investigation of such a complex ecosystem is difficult, even with culture independent molecular approaches...
  45. ncbi request reprint Mesalamine in the treatment of active Crohn's disease
    Axel Dignass
    Gastroenterology 128:245-6; author reply 246. 2005